Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (14)

2024

  1. Indicators to evaluate quality of care in head and neck cancer in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1089-1097

2023

  1. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2021

  1. Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020) (Clinical and Translational Oncology, (2021), 23, 5, (913-921), 10.1007/s12094-020-02533-1)

    Clinical and Translational Oncology

2020

  1. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. SEOM clinical guidelines for the treatment of head and neck cancer (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 75-83

2017

  1. Manejo de la infección y la neutropenia febril en el paciente con cáncer sólido

    Enfermedades Infecciosas y Microbiologia Clinica

2016

  1. Management of infection and febrile neutropenia in patients with solid cancer

    Clinical and Translational Oncology, Vol. 18, Núm. 6, pp. 557-570

  2. Quality indicators to assure and improve cancer care in Spain using the delphi technique

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558

2014

  1. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers

    Breast Cancer Research and Treatment, Vol. 148, Núm. 2, pp. 415-421

2013

  1. Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas

    PLoS ONE, Vol. 8, Núm. 9

  2. SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs)

    Clinical and Translational Oncology, Vol. 15, Núm. 1, pp. 20-25

2012

  1. Functions and workload of medical oncologists in Spain

    Clinical and Translational Oncology, Vol. 14, Núm. 6, pp. 423-429

  2. Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

    Annals of Oncology, Vol. 23, Núm. 4, pp. 1016-1022

2010

  1. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

    British Journal of Cancer, Vol. 102, Núm. 12, pp. 1687-1691